Health.Care | An Educational Blog

Making the Case for a Healthcare Innovation (Part 2): Assessing Risk

Making the Case for a Healthcare Innovation (Part 1): What Data Is Needed?

Clostridioides difficile: An Introduction

All
Infection Control
HAIs
Hospitals
Patient Safety
Bacteria
Research
History
Product Evaluation
Cleaning Protocols
Microbiology
Patient Advocacy
Germs
Design
Antibiotic Resistance
Consumer
Interventions
Cost-Effectiveness
Costs
Public Health
Copper
Epidemiology
Innovations
Regulation
Career
Health & Wellness
Medicare/Medicaid
Policy
Handwashing
Architecture
Long-Term Care Facilities (LTCFs)
Disinfectants
Science
Construction
Environmental Services
Infographics
MRSA
Antimicrobials
C. difficile
Evidence-Based Design
Black History Month
COVID-19
Centers for Disease Control and Prevention (CDC)
Contamination Statistics
MDROs
Surveillance
Women's History Month
Ecology
News
Public Reporting
Special Populations
Equity
Hispanic Heritage Month
Nurses
School & Children
Vaccines
Veterans
Cancer
Native Americans/First Peoples/Indian Americans
Outpatient/Ambulatory Facilities
Professional Profile
Viruses
Women
Bedrails
Conferences
Flu/Influenza
Globa Health
International
Medicines/Pharmaceuticals
Public Transit
Resources
Social Media
Data
Events
Fungi
Home Health Care
Mental Health
Risk mitigation

Assessing the potential risks and benefits is an important step before proposing a new product or program for your facility. You need to anticipate...

The first step in making a case for a healthcare innovation is collecting the data that supports it. This data includes evidence the the innovation...

C. diff, or Clostridioides difficile, is a Gram-positive, rod-shaped, anaerobic, endosporic, toxigenic, opportunistic, bacillus. Its scientific...